HEADLINE: The Early Bird Catches The Worm_EXCLUSIVE_Roche Partnership With MannKind (MNKD) To Be Announced In 14 Days On Friday, January 31st Projects Sierra World Equity Review.
It is a done deal, after months of work Sierra and her team now have pinpointed Friday, January 31st as the exact date that the news that Sierra broke first is expected to be be officially announced by the parties. Despite attempts by those shorting MannKind to create fear and panic selling, Sierra believes that both Roche and MannKind are very confident that MannKind's highly promising pipeline drug Afrezza will have a positive outcome following the FDA's Endocrinologic and Metabolic Drugs Advisory Committee review of MannKind's New Drug Application (NDA) for Afrezza scheduled for April 1, 2014. Sierra and her team continue to stay on top of potentially huge market moving developments, check back for updates.
Sierra is full of it. Again, a scam website that hasn't got ANYTHING right at all. According it Pfizer should have bought out almost every biotech right now and SPOM was the stock of 2013 during a week of pumping among other bogus picks.